regulatory strategybriefings.

Aerial view of three distinct currents flowing side by side without merging, symbolizing separate regulatory tracks that have not yet converged.

The Convergence Gap in AI Life Sciences Regulation

Regulators describe AI, digital health, and clinical trial law as converging, but FDA, UK, and Chinese actions show the frameworks are still moving on separate, misaligned tracks.

Molecular structures blending into a tangled network of glowing nodes, symbolizing the shift from complicated to complex AI systems in drug discovery.

Complicated Is Not Complex: The Governance Gap in AI Drug Discovery

Drug discovery leaders are validating AI systems as if they were complicated, when the real risk is that they behave as complex, emergent systems.

A stationary regulatory rulebook against a blur of fast-moving digital data trails, symbolizing regulation lagging AI velocity.

The Guidance Cannot Outrun the Model

FDA and EU regulators are structurally too slow to govern AI at the pace it changes, so life sciences compliance leaders must build internal governance now.